MGLL and colon carcinoma: In previously published work, MAGL inhibitor-induced reduction in colon carcinoma xenograft growth was accompanied by decreased VEGF and fibroblast growth factor (FGF)-2 expression [12], suggesting the involvement of antiangiogenic mechanisms of action.